While I'm not happy about all of this,,I'm sure management, who owns a lot of shares have
a handle on what's going on. So,,I have to believe this price is a good deal...Won't be long
and I'm going to be getting a call from Phil Mickelson..wanting to know what I'm thinking.
Greg Wade ( phD) left Wedbush and his recc behind , but since it was a polarizing call ...... Greg went to work for Pharmacyclics .. a company I use to own. Dr Wade called for additional trialing of Arikayce and that Insmed did not /would not have the needed information from trialing the FDA demands. Now INSM is 5 bucks from his call ,but those that shorted after the results ( uhmm I blush) have done well. 19.79 to 11.87
- "Biotech sector has reset-Piper J $51 -who would believe such a thing ? by terry_insm • Apr 25, 2014 "
Gonna take quite the news releases to get this back to $20. And IF it does, some of us will certainly be lamenting/wondering that it should/could have been $30. or more if not for Gupta's trial design and now Lewis hammering us and gifting his Wall St. colleagues.
Wade/Webush were right, all along.
I have expressed my feelings to the company regarding the timing of this shelf offering with no accompanying statement regarding the potential timing of any execution. I have also asked them to release the exact date of the Breakthrough Therapy filing and any progress on the number of culture negative patients.